Alvotech, a biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and Advanz Pharma Holdco Limited, a pharmaceutical company with a strategic focus on specialty, hospital, and rare disease medicines in Europe, have been granted marketing authorizations for all four presentations of Gobivaz, Alvotech’s biosimilar to Simponi (golimumab), by the UK Medicines and Healthcare products Regulatory Agency (MHRA). The authorizations cover Gobiva...